Dr. Fakeeh Hospital Reports SAR 38.41M Net Profit in Three Months 2026
FAKEEH CARE 4017.SA | 0.00 |
On 2026-05-06 08:41:22 (Saudi Time), Dr. Soliman Abdel Kader Fakeeh Hospital Co. announced its Interim financial results for the three months ended on March 31, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 724.15 | 701.02 | 3.299 | 799.12 | -9.381 |
| Gross Profit (Loss) | 139.9 | 176.14 | -20.574 | 169.89 | -17.652 |
| Operational Profit (Loss) | 44.61 | 76.98 | -42.049 | 75.28 | -40.741 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 38.41 | 72.2 | -46.8 | 64.22 | -40.189 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 38.41 | 72.2 | -46.8 | 56.62 | -32.161 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 3,211.62 | 3,172.03 | 1.248 |
| Profit (Loss) per Share | 0.17 | 0.31 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
Sales increased 3.299% YoY to SAR 724.15 million driven by 1% more outpatients, 11% more inpatients, 17% more surgical procedures, and strong 78% growth in New Business revenue from DSFH Riyadh and DSFH Madinah expansions. However, net profit declined 46.8% YoY to SAR 38.41 million primarily due to prolonged Ramadan and Eid Al Fitr seasonality reducing effective operating days, which spread fixed costs across a smaller revenue base. Profitability was further impacted by ramp-up costs at DSFH Madinah, including front-loaded staffing and depreciation expenses that were not present in the prior year period.
Quarter-on-Quarter Performance Drivers
QoQ revenue declined 9.381% to SAR 724.15 million primarily due to Ramadan and Eid Al Fitr seasonal calendar effects in Q1 2026, which reduced effective operating days and patient volumes compared to Q4 2025. Net profit fell 40.189% to SAR 38.41 million as the SAR 75 million revenue decrease outweighed the SAR 45 million reduction in aggregate COGS and SG&A expenses. The reduced operating days lowered patient volumes and revenue while fixed costs remained largely unchanged, resulting in poor cost absorption across the smaller revenue base.
Other Items
The auditors issued an unmodified conclusion with no additional comments, disclaimers, or adverse opinions noted. Total shareholders equity increased 1.248% year-over-year to SAR 3,211.62 million. Earnings per share decreased from SAR 0.31 to SAR 0.17 compared to the same quarter last year. No accumulated losses or material uncertainties regarding going concern were reported in this interim financial statement.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=95008&anCat=1&cs=4017&locale=arAttached PDF document link:
https://www.saudiexchange.sa/Resources/fsPdf/20894_5826_2026-05-06_01-38-26_en.pdfImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.